View More Recent Stories

Apr 11, 2025 05:09AM Jefferies Upgrades Nektar Therapeutics (NKTR) to Buy
Mar 28, 2025 04:24PM Nektar Therapeutics (NKTR) Files $300M Mixed Shelf
Mar 14, 2025 01:55AM Oppenheimer Upgrades Nektar Therapeutics (NKTR) to Outperform
Mar 13, 2025 04:46AM BTIG Reiterates Neutral Rating on Nektar Therapeutics (NKTR)
Mar 13, 2025 04:34AM Nektar Therapeutics (NKTR) PT Lowered to $1 at Jefferies
Mar 12, 2025 04:17PM Nektar Therapeutics (NKTR) Tops Q4 EPS by 19c
Feb 26, 2025 07:01AM Nektar Therapeutics (NKTR) Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin
Feb 25, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Feb 24, 2025 11:29PM Piper Sandler Reiterates Overweight Rating on Nektar Therapeutics (NKTR)
Feb 24, 2025 07:00AM Nektar Therapeutics (NKTR) Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus
Feb 10, 2025 07:01AM Nektar Therapeutics (NKTR) Receives Fast Track Designation for Rezpegaldesleukin
Jan 10, 2025 07:03AM Nektar Therapeutics (NKTR) competes target enrollment in its REZOLVE-AD Phase 2b study
Jan 7, 2025 11:35PM B.Riley Starts Nektar Therapeutics (NKTR) at Buy
Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Dec 10, 2024 06:36AM H.C. Wainwright Starts Nektar Therapeutics (NKTR) at Buy
Nov 7, 2024 04:32PM Nektar Therapeutics (NKTR) Tops Q3 EPS by 2c
Nov 7, 2024 10:16AM Nektar Therapeutics (NKTR) and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255
Nov 4, 2024 08:30AM Nektar Therapeutics (NKTR) to Sell Commercial PEGylation Reagent Manufacturing Business in Alabama
Nov 4, 2024 12:30AM Piper Sandler Starts Nektar Therapeutics (NKTR) at Overweight
Oct 29, 2024 09:02AM Nektar Therapeutics (NKTR) Announces Publication of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
Oct 17, 2024 12:07PM Nektar Therapeutics (NKTR) Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy
Sep 30, 2024 07:21AM BTIG Assumes Nektar Therapeutics (NKTR) at Buy
Aug 8, 2024 05:13PM Nektar Therapeutics (NKTR) Misses Q2 EPS by 6c
Jun 12, 2024 09:30AM Nektar Therapeutics (NKTR) Presents First Preclinical Data on NKTR-0165
View More Recent Stories